ATE328491T1 - Peptiden reich an cystein und/oder glycin - Google Patents

Peptiden reich an cystein und/oder glycin

Info

Publication number
ATE328491T1
ATE328491T1 AT00203699T AT00203699T ATE328491T1 AT E328491 T1 ATE328491 T1 AT E328491T1 AT 00203699 T AT00203699 T AT 00203699T AT 00203699 T AT00203699 T AT 00203699T AT E328491 T1 ATE328491 T1 AT E328491T1
Authority
AT
Austria
Prior art keywords
peptides
cysteine
cystein
glycine
preparation
Prior art date
Application number
AT00203699T
Other languages
English (en)
Inventor
Leon Franciscus Mallee
Ram Nimmagudda
Johannes Wilhelmus Leo Boumans
Original Assignee
Campina Melkunie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Campina Melkunie Bv filed Critical Campina Melkunie Bv
Application granted granted Critical
Publication of ATE328491T1 publication Critical patent/ATE328491T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00203699T 2000-10-24 2000-10-24 Peptiden reich an cystein und/oder glycin ATE328491T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203699A EP1201137B1 (de) 2000-10-24 2000-10-24 Peptiden reich an Cystein und/oder Glycin

Publications (1)

Publication Number Publication Date
ATE328491T1 true ATE328491T1 (de) 2006-06-15

Family

ID=8172176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00203699T ATE328491T1 (de) 2000-10-24 2000-10-24 Peptiden reich an cystein und/oder glycin

Country Status (9)

Country Link
US (1) US6620778B2 (de)
EP (1) EP1201137B1 (de)
JP (2) JP4293745B2 (de)
AT (1) ATE328491T1 (de)
AU (1) AU783732B2 (de)
CA (1) CA2359606A1 (de)
DE (1) DE60028575T2 (de)
DK (1) DK1201137T3 (de)
NZ (1) NZ515005A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224096A1 (en) * 2002-06-04 2003-12-04 Novozymes A/S Whey protein hydrolysate
EP1517619B1 (de) * 2002-07-01 2007-01-03 Unilever N.V. Zusammensetzung, die ein sättigungsgefühl hervorruft
US6787168B1 (en) * 2003-03-18 2004-09-07 James W. Sawhill Peptide product
GB2403475B (en) * 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
US20080032915A1 (en) * 2004-02-12 2008-02-07 Campina Nederland Holding B.V. Cysteine Rich Peptides for Improving Thiol Homeostasis
EP1723951A1 (de) 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
DK1831361T3 (da) 2004-12-23 2012-05-14 Campina Nederland Holding Bv Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20080199512A1 (en) * 2005-09-02 2008-08-21 Steffi Dudek Oral Composition For Moisturizing Skin
JP2009517464A (ja) * 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
US8637325B2 (en) * 2009-02-16 2014-01-28 University Of Wyoming Method and apparatus for pyrolysis-induced cleavage in peptides and proteins
US20100069288A1 (en) * 2008-09-12 2010-03-18 Wulf Droge Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
WO2010147456A1 (en) 2009-06-19 2010-12-23 N.V. Nutricia Inhibition of nfk-b mediated virus replication with specific oligosaccharides
NL2006807C2 (en) 2011-01-31 2012-08-01 Primeval B V Nutritional composition for equine reproductive health.
WO2012138213A1 (en) 2011-04-08 2012-10-11 N.V. Nutricia Reduction of vascular dysfunction with specific saccharides
CN103005142B (zh) * 2012-12-13 2014-01-15 内蒙古伊利实业集团股份有限公司 α-乳白蛋白水解物及其制备方法与应用
CN103146791A (zh) * 2013-03-13 2013-06-12 扬州大学 多种蛋白酶水解蛋清蛋白的方法
JP2023522059A (ja) * 2020-04-20 2023-05-26 エボニック オペレーションズ ゲーエムベーハー Ｃｙｓ－ペプチドを含む組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
US5464825A (en) * 1991-03-14 1995-11-07 Cornell Research Foundation, Inc. Raising glutathione equivalent levels using N-acyl glutathione monoesters
DE4130284A1 (de) 1991-09-12 1993-03-18 Willi Prof Dr Med Habil Heine Verfahren zur herstellung biologisch hochwertiger nahrungseiweisse
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
JP3979543B2 (ja) 1994-01-31 2007-09-19 雪印乳業株式会社 抗アレルギー剤及びその製造法
FR2758330B1 (fr) * 1997-01-10 1999-03-26 Roquette Freres Composition azotee resultant de l'hydrolyse du gluten de ble et son procede de fabrication
ATE304796T1 (de) * 1997-04-04 2005-10-15 Monsanto Technology Llc Produkte mit hohem beta-conglycinin-gehalt und ihre verwendung

Also Published As

Publication number Publication date
AU8156701A (en) 2002-05-02
NZ515005A (en) 2003-07-25
US6620778B2 (en) 2003-09-16
JP2003033197A (ja) 2003-02-04
DK1201137T3 (da) 2006-07-17
AU783732B2 (en) 2005-12-01
JP2009112312A (ja) 2009-05-28
CA2359606A1 (en) 2002-04-24
JP4348402B2 (ja) 2009-10-21
US20020090670A1 (en) 2002-07-11
JP4293745B2 (ja) 2009-07-08
EP1201137B1 (de) 2006-06-07
EP1201137A1 (de) 2002-05-02
DE60028575D1 (de) 2006-07-20
DE60028575T2 (de) 2007-06-28

Similar Documents

Publication Publication Date Title
DE60028575D1 (de) Peptiden reich an Cystein und/oder Glycin
EA200400632A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
WO2002048183A3 (en) Compositions of peptide crystals
ATE483729T1 (de) Peptid
DE50004018D1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
WO2003057881A1 (en) Method of stabilizing protein
AR012010A1 (es) Metodo para el procesamiento de una solucion acuosa de proteina c activada
AU5989499A (en) Method for prevention and/or cosmetic treatment of skin striae and use in dermatology
AP9901686A0 (en) Peptide parathyroid hormone analogs.
UA66758C2 (en) Pharmaceutical formulations comprising growth hormone, method for its production and method for treatment
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
DK1223990T3 (da) Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
EA200600128A1 (ru) Способ уничтожения раковых клеток (варианты), фармацевтическое средство (варианты) и набор для его осуществления
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
EP1281763A3 (de) Early growth response-1 (EGR-1) transkriptions-faktor
MXPA02008276A (es) Compuestos de tiazolio y tratamientos de trastornos asociados con el envejecimiento proteinico.
ATE401400T1 (de) Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
DK1339735T3 (da) Fremgangsmåde til fremstilling af tryptophanrige peptider
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
EP1374887A4 (de) Neue mittel zur linderung von motorischen störungen
MXPA03006266A (es) Uso de l-carnitina como agente estabilizador de proteinas.
DE60229281D1 (de) Modifizierte molkenproteinzusammensetzungen mit verbesserten schäumeigenschaften
WO1995007987A3 (en) Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties